Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
Oncogene
|
January 8, 1999
ETS2 function is required to maintain the transformed state of human prostate cancer cells
V I Sementchenko, C W Schweinfest, T S Papas, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway
J Czuwara-Ladykowska, F Shirasaki, P Jackers, et al.
Oncogene
|
April 1, 1991
The human ETS1 gene: genomic structure, promoter characterization and alternative splicing
C L Jorcyk, D K Watson, G J Mavrothalassitis, et al.
Cancer Gene Therapy
|
September 7, 2000
Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids
M Athanasiou, L LeGallic, D K Watson, et al.
Oncogene
|
July 1, 1991
D-elg, a member of the Drosophila ets gene family: sequence, expression and evolutionary comparison
L J Pribyl, D K Watson, R A Schulz, et al.
British Journal of Haematology
|
March 1, 1980
Citrate induced hypocalcaemia during cell separation
D K Watson, A F Penny, R W Marshall, et al.
The Journal of the American Osteopathic Association
|
April 1, 1991
A selective approach to operative cholangiography
A H Olivencia-Yurvati, D K Watson, R E Jackson, et al.
Oncogene
|
July 1, 1993
Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody
A Seth, L Robinson, D M Thompson, et al.
Oncogene Research
|
January 1, 1989
Expression of human and viral ets genes in E. coli production of human ets-2-specific monoclonal antibodies
A Seth, D K Watson, S Fujiwara, et al.
Oncogene
|
February 1, 1994
Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis
G Mavrothalassitis, R J Fisher, F Smyth, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
Oncogene
|
January 8, 1999
ETS2 function is required to maintain the transformed state of human prostate cancer cells
V I Sementchenko, C W Schweinfest, T S Papas, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway
J Czuwara-Ladykowska, F Shirasaki, P Jackers, et al.
Oncogene
|
April 1, 1991
The human ETS1 gene: genomic structure, promoter characterization and alternative splicing
C L Jorcyk, D K Watson, G J Mavrothalassitis, et al.
Cancer Gene Therapy
|
September 7, 2000
Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids
M Athanasiou, L LeGallic, D K Watson, et al.
Oncogene
|
July 1, 1991
D-elg, a member of the Drosophila ets gene family: sequence, expression and evolutionary comparison
L J Pribyl, D K Watson, R A Schulz, et al.
British Journal of Haematology
|
March 1, 1980
Citrate induced hypocalcaemia during cell separation
D K Watson, A F Penny, R W Marshall, et al.
The Journal of the American Osteopathic Association
|
April 1, 1991
A selective approach to operative cholangiography
A H Olivencia-Yurvati, D K Watson, R E Jackson, et al.
Oncogene
|
July 1, 1993
Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody
A Seth, L Robinson, D M Thompson, et al.
Oncogene Research
|
January 1, 1989
Expression of human and viral ets genes in E. coli production of human ets-2-specific monoclonal antibodies
A Seth, D K Watson, S Fujiwara, et al.
Oncogene
|
February 1, 1994
Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis
G Mavrothalassitis, R J Fisher, F Smyth, et al.
Page
of 9